0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Phenylpropanolamine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-15L8332
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Phenylpropanolamine Market Insights Forecast to 2028
BUY CHAPTERS

Global Phenylpropanolamine Market Research Report 2025

Code: QYRE-Auto-15L8332
Report
July 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Phenylpropanolamine Market Size

The global market for Phenylpropanolamine was valued at US$ 1712 million in the year 2024 and is projected to reach a revised size of US$ 2382 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Phenylpropanolamine Market

Phenylpropanolamine Market

Phenylpropanolamine (PPA) is a sympathomimetic agent which is used as a decongestant and appetite suppressant. It was commonly used in prescription and over-the-counter cough and cold preparations. In veterinary medicine, it is used to control urinary incontinence in dogs
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Phenylpropanolamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phenylpropanolamine.
The Phenylpropanolamine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Phenylpropanolamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phenylpropanolamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Phenylpropanolamine Market Report

Report Metric Details
Report Name Phenylpropanolamine Market
Accounted market size in year US$ 1712 million
Forecasted market size in 2031 US$ 2382 million
CAGR 4.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Tablet
  • Capsule
  • Syrup
Segment by Application
  • Human
  • Veterinary
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Riemser Pharma, Abbott, Gräub, Helicon, Eipico, Schazoo, GlaxoSmithKline (GSK), Roemmers, Armoxindo, Asuncion, Medlink, Sanofi-Aventis, Tempo Scan Pacific, Carinopharm, Meda, IBL Healthcare, Gracia Pharmindo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Phenylpropanolamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Phenylpropanolamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Phenylpropanolamine Market growing?

Ans: The Phenylpropanolamine Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the Phenylpropanolamine Market size in 2031?

Ans: The Phenylpropanolamine Market size in 2031 will be US$ 2382 million.

Who are the main players in the Phenylpropanolamine Market report?

Ans: The main players in the Phenylpropanolamine Market are Riemser Pharma, Abbott, Gräub, Helicon, Eipico, Schazoo, GlaxoSmithKline (GSK), Roemmers, Armoxindo, Asuncion, Medlink, Sanofi-Aventis, Tempo Scan Pacific, Carinopharm, Meda, IBL Healthcare, Gracia Pharmindo

What are the Application segmentation covered in the Phenylpropanolamine Market report?

Ans: The Applications covered in the Phenylpropanolamine Market report are Human, Veterinary

What are the Type segmentation covered in the Phenylpropanolamine Market report?

Ans: The Types covered in the Phenylpropanolamine Market report are Tablet, Capsule, Syrup

Recommended Reports

Pharmaceutical Ingredients

Therapeutics & Medications

Device & Support Markets

1 Phenylpropanolamine Market Overview
1.1 Product Definition
1.2 Phenylpropanolamine by Type
1.2.1 Global Phenylpropanolamine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Syrup
1.3 Phenylpropanolamine by Application
1.3.1 Global Phenylpropanolamine Market Value by Application (2024 VS 2031)
1.3.2 Human
1.3.3 Veterinary
1.4 Global Phenylpropanolamine Market Size Estimates and Forecasts
1.4.1 Global Phenylpropanolamine Revenue 2020-2031
1.4.2 Global Phenylpropanolamine Sales 2020-2031
1.4.3 Global Phenylpropanolamine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Phenylpropanolamine Market Competition by Manufacturers
2.1 Global Phenylpropanolamine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Phenylpropanolamine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Phenylpropanolamine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Phenylpropanolamine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Phenylpropanolamine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Phenylpropanolamine, Product Type & Application
2.7 Global Key Manufacturers of Phenylpropanolamine, Date of Enter into This Industry
2.8 Global Phenylpropanolamine Market Competitive Situation and Trends
2.8.1 Global Phenylpropanolamine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Phenylpropanolamine Players Market Share by Revenue
2.8.3 Global Phenylpropanolamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Phenylpropanolamine Market Scenario by Region
3.1 Global Phenylpropanolamine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Phenylpropanolamine Sales by Region: 2020-2031
3.2.1 Global Phenylpropanolamine Sales by Region: 2020-2025
3.2.2 Global Phenylpropanolamine Sales by Region: 2026-2031
3.3 Global Phenylpropanolamine Revenue by Region: 2020-2031
3.3.1 Global Phenylpropanolamine Revenue by Region: 2020-2025
3.3.2 Global Phenylpropanolamine Revenue by Region: 2026-2031
3.4 North America Phenylpropanolamine Market Facts & Figures by Country
3.4.1 North America Phenylpropanolamine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Phenylpropanolamine Sales by Country (2020-2031)
3.4.3 North America Phenylpropanolamine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Phenylpropanolamine Market Facts & Figures by Country
3.5.1 Europe Phenylpropanolamine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Phenylpropanolamine Sales by Country (2020-2031)
3.5.3 Europe Phenylpropanolamine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Phenylpropanolamine Market Facts & Figures by Region
3.6.1 Asia Pacific Phenylpropanolamine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Phenylpropanolamine Sales by Region (2020-2031)
3.6.3 Asia Pacific Phenylpropanolamine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Phenylpropanolamine Market Facts & Figures by Country
3.7.1 Latin America Phenylpropanolamine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Phenylpropanolamine Sales by Country (2020-2031)
3.7.3 Latin America Phenylpropanolamine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Phenylpropanolamine Market Facts & Figures by Country
3.8.1 Middle East and Africa Phenylpropanolamine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Phenylpropanolamine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Phenylpropanolamine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Phenylpropanolamine Sales by Type (2020-2031)
4.1.1 Global Phenylpropanolamine Sales by Type (2020-2025)
4.1.2 Global Phenylpropanolamine Sales by Type (2026-2031)
4.1.3 Global Phenylpropanolamine Sales Market Share by Type (2020-2031)
4.2 Global Phenylpropanolamine Revenue by Type (2020-2031)
4.2.1 Global Phenylpropanolamine Revenue by Type (2020-2025)
4.2.2 Global Phenylpropanolamine Revenue by Type (2026-2031)
4.2.3 Global Phenylpropanolamine Revenue Market Share by Type (2020-2031)
4.3 Global Phenylpropanolamine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Phenylpropanolamine Sales by Application (2020-2031)
5.1.1 Global Phenylpropanolamine Sales by Application (2020-2025)
5.1.2 Global Phenylpropanolamine Sales by Application (2026-2031)
5.1.3 Global Phenylpropanolamine Sales Market Share by Application (2020-2031)
5.2 Global Phenylpropanolamine Revenue by Application (2020-2031)
5.2.1 Global Phenylpropanolamine Revenue by Application (2020-2025)
5.2.2 Global Phenylpropanolamine Revenue by Application (2026-2031)
5.2.3 Global Phenylpropanolamine Revenue Market Share by Application (2020-2031)
5.3 Global Phenylpropanolamine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Riemser Pharma
6.1.1 Riemser Pharma Company Information
6.1.2 Riemser Pharma Description and Business Overview
6.1.3 Riemser Pharma Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Riemser Pharma Phenylpropanolamine Product Portfolio
6.1.5 Riemser Pharma Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abbott Phenylpropanolamine Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Gräub
6.3.1 Gräub Company Information
6.3.2 Gräub Description and Business Overview
6.3.3 Gräub Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gräub Phenylpropanolamine Product Portfolio
6.3.5 Gräub Recent Developments/Updates
6.4 Helicon
6.4.1 Helicon Company Information
6.4.2 Helicon Description and Business Overview
6.4.3 Helicon Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Helicon Phenylpropanolamine Product Portfolio
6.4.5 Helicon Recent Developments/Updates
6.5 Eipico
6.5.1 Eipico Company Information
6.5.2 Eipico Description and Business Overview
6.5.3 Eipico Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Eipico Phenylpropanolamine Product Portfolio
6.5.5 Eipico Recent Developments/Updates
6.6 Schazoo
6.6.1 Schazoo Company Information
6.6.2 Schazoo Description and Business Overview
6.6.3 Schazoo Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Schazoo Phenylpropanolamine Product Portfolio
6.6.5 Schazoo Recent Developments/Updates
6.7 GlaxoSmithKline (GSK)
6.7.1 GlaxoSmithKline (GSK) Company Information
6.7.2 GlaxoSmithKline (GSK) Description and Business Overview
6.7.3 GlaxoSmithKline (GSK) Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GlaxoSmithKline (GSK) Phenylpropanolamine Product Portfolio
6.7.5 GlaxoSmithKline (GSK) Recent Developments/Updates
6.8 Roemmers
6.8.1 Roemmers Company Information
6.8.2 Roemmers Description and Business Overview
6.8.3 Roemmers Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Roemmers Phenylpropanolamine Product Portfolio
6.8.5 Roemmers Recent Developments/Updates
6.9 Armoxindo
6.9.1 Armoxindo Company Information
6.9.2 Armoxindo Description and Business Overview
6.9.3 Armoxindo Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Armoxindo Phenylpropanolamine Product Portfolio
6.9.5 Armoxindo Recent Developments/Updates
6.10 Asuncion
6.10.1 Asuncion Company Information
6.10.2 Asuncion Description and Business Overview
6.10.3 Asuncion Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Asuncion Phenylpropanolamine Product Portfolio
6.10.5 Asuncion Recent Developments/Updates
6.11 Medlink
6.11.1 Medlink Company Information
6.11.2 Medlink Description and Business Overview
6.11.3 Medlink Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Medlink Phenylpropanolamine Product Portfolio
6.11.5 Medlink Recent Developments/Updates
6.12 Sanofi-Aventis
6.12.1 Sanofi-Aventis Company Information
6.12.2 Sanofi-Aventis Description and Business Overview
6.12.3 Sanofi-Aventis Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sanofi-Aventis Phenylpropanolamine Product Portfolio
6.12.5 Sanofi-Aventis Recent Developments/Updates
6.13 Tempo Scan Pacific
6.13.1 Tempo Scan Pacific Company Information
6.13.2 Tempo Scan Pacific Description and Business Overview
6.13.3 Tempo Scan Pacific Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Tempo Scan Pacific Phenylpropanolamine Product Portfolio
6.13.5 Tempo Scan Pacific Recent Developments/Updates
6.14 Carinopharm
6.14.1 Carinopharm Company Information
6.14.2 Carinopharm Description and Business Overview
6.14.3 Carinopharm Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Carinopharm Phenylpropanolamine Product Portfolio
6.14.5 Carinopharm Recent Developments/Updates
6.15 Meda
6.15.1 Meda Company Information
6.15.2 Meda Description and Business Overview
6.15.3 Meda Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Meda Phenylpropanolamine Product Portfolio
6.15.5 Meda Recent Developments/Updates
6.16 IBL Healthcare
6.16.1 IBL Healthcare Company Information
6.16.2 IBL Healthcare Description and Business Overview
6.16.3 IBL Healthcare Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 IBL Healthcare Phenylpropanolamine Product Portfolio
6.16.5 IBL Healthcare Recent Developments/Updates
6.17 Gracia Pharmindo
6.17.1 Gracia Pharmindo Company Information
6.17.2 Gracia Pharmindo Description and Business Overview
6.17.3 Gracia Pharmindo Phenylpropanolamine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Gracia Pharmindo Phenylpropanolamine Product Portfolio
6.17.5 Gracia Pharmindo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Phenylpropanolamine Industry Chain Analysis
7.2 Phenylpropanolamine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Phenylpropanolamine Production Mode & Process Analysis
7.4 Phenylpropanolamine Sales and Marketing
7.4.1 Phenylpropanolamine Sales Channels
7.4.2 Phenylpropanolamine Distributors
7.5 Phenylpropanolamine Customer Analysis
8 Phenylpropanolamine Market Dynamics
8.1 Phenylpropanolamine Industry Trends
8.2 Phenylpropanolamine Market Drivers
8.3 Phenylpropanolamine Market Challenges
8.4 Phenylpropanolamine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Phenylpropanolamine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Phenylpropanolamine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Phenylpropanolamine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Phenylpropanolamine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Phenylpropanolamine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Phenylpropanolamine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Phenylpropanolamine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Phenylpropanolamine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Phenylpropanolamine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Phenylpropanolamine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Phenylpropanolamine, Product Type & Application
 Table 12. Global Key Manufacturers of Phenylpropanolamine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Phenylpropanolamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenylpropanolamine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Phenylpropanolamine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Phenylpropanolamine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Phenylpropanolamine Sales Market Share by Region (2020-2025)
 Table 19. Global Phenylpropanolamine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Phenylpropanolamine Sales Market Share by Region (2026-2031)
 Table 21. Global Phenylpropanolamine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Phenylpropanolamine Revenue Market Share by Region (2020-2025)
 Table 23. Global Phenylpropanolamine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Phenylpropanolamine Revenue Market Share by Region (2026-2031)
 Table 25. North America Phenylpropanolamine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Phenylpropanolamine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Phenylpropanolamine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Phenylpropanolamine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Phenylpropanolamine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Phenylpropanolamine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Phenylpropanolamine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Phenylpropanolamine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Phenylpropanolamine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Phenylpropanolamine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Phenylpropanolamine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Phenylpropanolamine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Phenylpropanolamine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Phenylpropanolamine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Phenylpropanolamine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Phenylpropanolamine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Phenylpropanolamine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Phenylpropanolamine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Phenylpropanolamine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Phenylpropanolamine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Phenylpropanolamine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Phenylpropanolamine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Phenylpropanolamine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Phenylpropanolamine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Phenylpropanolamine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Phenylpropanolamine Sales (K Units) by Type (2020-2025)
 Table 51. Global Phenylpropanolamine Sales (K Units) by Type (2026-2031)
 Table 52. Global Phenylpropanolamine Sales Market Share by Type (2020-2025)
 Table 53. Global Phenylpropanolamine Sales Market Share by Type (2026-2031)
 Table 54. Global Phenylpropanolamine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Phenylpropanolamine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Phenylpropanolamine Revenue Market Share by Type (2020-2025)
 Table 57. Global Phenylpropanolamine Revenue Market Share by Type (2026-2031)
 Table 58. Global Phenylpropanolamine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Phenylpropanolamine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Phenylpropanolamine Sales (K Units) by Application (2020-2025)
 Table 61. Global Phenylpropanolamine Sales (K Units) by Application (2026-2031)
 Table 62. Global Phenylpropanolamine Sales Market Share by Application (2020-2025)
 Table 63. Global Phenylpropanolamine Sales Market Share by Application (2026-2031)
 Table 64. Global Phenylpropanolamine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Phenylpropanolamine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Phenylpropanolamine Revenue Market Share by Application (2020-2025)
 Table 67. Global Phenylpropanolamine Revenue Market Share by Application (2026-2031)
 Table 68. Global Phenylpropanolamine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Phenylpropanolamine Price (US$/Unit) by Application (2026-2031)
 Table 70. Riemser Pharma Company Information
 Table 71. Riemser Pharma Description and Business Overview
 Table 72. Riemser Pharma Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Riemser Pharma Phenylpropanolamine Product
 Table 74. Riemser Pharma Recent Developments/Updates
 Table 75. Abbott Company Information
 Table 76. Abbott Description and Business Overview
 Table 77. Abbott Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Abbott Phenylpropanolamine Product
 Table 79. Abbott Recent Developments/Updates
 Table 80. Gräub Company Information
 Table 81. Gräub Description and Business Overview
 Table 82. Gräub Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Gräub Phenylpropanolamine Product
 Table 84. Gräub Recent Developments/Updates
 Table 85. Helicon Company Information
 Table 86. Helicon Description and Business Overview
 Table 87. Helicon Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Helicon Phenylpropanolamine Product
 Table 89. Helicon Recent Developments/Updates
 Table 90. Eipico Company Information
 Table 91. Eipico Description and Business Overview
 Table 92. Eipico Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Eipico Phenylpropanolamine Product
 Table 94. Eipico Recent Developments/Updates
 Table 95. Schazoo Company Information
 Table 96. Schazoo Description and Business Overview
 Table 97. Schazoo Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Schazoo Phenylpropanolamine Product
 Table 99. Schazoo Recent Developments/Updates
 Table 100. GlaxoSmithKline (GSK) Company Information
 Table 101. GlaxoSmithKline (GSK) Description and Business Overview
 Table 102. GlaxoSmithKline (GSK) Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. GlaxoSmithKline (GSK) Phenylpropanolamine Product
 Table 104. GlaxoSmithKline (GSK) Recent Developments/Updates
 Table 105. Roemmers Company Information
 Table 106. Roemmers Description and Business Overview
 Table 107. Roemmers Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Roemmers Phenylpropanolamine Product
 Table 109. Roemmers Recent Developments/Updates
 Table 110. Armoxindo Company Information
 Table 111. Armoxindo Description and Business Overview
 Table 112. Armoxindo Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Armoxindo Phenylpropanolamine Product
 Table 114. Armoxindo Recent Developments/Updates
 Table 115. Asuncion Company Information
 Table 116. Asuncion Description and Business Overview
 Table 117. Asuncion Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Asuncion Phenylpropanolamine Product
 Table 119. Asuncion Recent Developments/Updates
 Table 120. Medlink Company Information
 Table 121. Medlink Description and Business Overview
 Table 122. Medlink Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Medlink Phenylpropanolamine Product
 Table 124. Medlink Recent Developments/Updates
 Table 125. Sanofi-Aventis Company Information
 Table 126. Sanofi-Aventis Description and Business Overview
 Table 127. Sanofi-Aventis Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Sanofi-Aventis Phenylpropanolamine Product
 Table 129. Sanofi-Aventis Recent Developments/Updates
 Table 130. Tempo Scan Pacific Company Information
 Table 131. Tempo Scan Pacific Description and Business Overview
 Table 132. Tempo Scan Pacific Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Tempo Scan Pacific Phenylpropanolamine Product
 Table 134. Tempo Scan Pacific Recent Developments/Updates
 Table 135. Carinopharm Company Information
 Table 136. Carinopharm Description and Business Overview
 Table 137. Carinopharm Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Carinopharm Phenylpropanolamine Product
 Table 139. Carinopharm Recent Developments/Updates
 Table 140. Meda Company Information
 Table 141. Meda Description and Business Overview
 Table 142. Meda Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Meda Phenylpropanolamine Product
 Table 144. Meda Recent Developments/Updates
 Table 145. IBL Healthcare Company Information
 Table 146. IBL Healthcare Description and Business Overview
 Table 147. IBL Healthcare Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. IBL Healthcare Phenylpropanolamine Product
 Table 149. IBL Healthcare Recent Developments/Updates
 Table 150. Gracia Pharmindo Company Information
 Table 151. Gracia Pharmindo Description and Business Overview
 Table 152. Gracia Pharmindo Phenylpropanolamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Gracia Pharmindo Phenylpropanolamine Product
 Table 154. Gracia Pharmindo Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Phenylpropanolamine Distributors List
 Table 158. Phenylpropanolamine Customers List
 Table 159. Phenylpropanolamine Market Trends
 Table 160. Phenylpropanolamine Market Drivers
 Table 161. Phenylpropanolamine Market Challenges
 Table 162. Phenylpropanolamine Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Phenylpropanolamine
 Figure 2. Global Phenylpropanolamine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Phenylpropanolamine Market Share by Type: 2024 & 2031
 Figure 4. Tablet Product Picture
 Figure 5. Capsule Product Picture
 Figure 6. Syrup Product Picture
 Figure 7. Global Phenylpropanolamine Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Phenylpropanolamine Market Share by Application: 2024 & 2031
 Figure 9. Human
 Figure 10. Veterinary
 Figure 11. Global Phenylpropanolamine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Phenylpropanolamine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Phenylpropanolamine Sales (2020-2031) & (K Units)
 Figure 14. Global Phenylpropanolamine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Phenylpropanolamine Report Years Considered
 Figure 16. Phenylpropanolamine Sales Share by Manufacturers in 2024
 Figure 17. Global Phenylpropanolamine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Phenylpropanolamine Players: Market Share by Revenue in Phenylpropanolamine in 2024
 Figure 19. Phenylpropanolamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Phenylpropanolamine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Phenylpropanolamine Sales Market Share by Country (2020-2031)
 Figure 22. North America Phenylpropanolamine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Phenylpropanolamine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Phenylpropanolamine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Phenylpropanolamine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Phenylpropanolamine Revenue Market Share by Region (2020-2031)
 Figure 34. China Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Phenylpropanolamine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Phenylpropanolamine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Phenylpropanolamine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Phenylpropanolamine Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Phenylpropanolamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Phenylpropanolamine by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Phenylpropanolamine by Type (2020-2031)
 Figure 55. Global Phenylpropanolamine Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Phenylpropanolamine by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Phenylpropanolamine by Application (2020-2031)
 Figure 58. Global Phenylpropanolamine Price (US$/Unit) by Application (2020-2031)
 Figure 59. Phenylpropanolamine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure